Literature DB >> 848981

Depressed immune function in epidermodysplasia verruciformis.

S E Prawer, F Pass, J C Vance, L J Greenberg, E J Yunis, A S Zelickson.   

Abstract

Epidermodysplasia verruciformis (EV) is a rare disease characterized by the early onset and unremitting progression of wart-like lesions and frequent association of cutaneous carcinomas. We report two siblings with EV. Immunologic study of both patients demonstrated normal immunoglobulin levels, normal numbers of T-lymphocytes and B-lymphocytes, but markedly depressed in vitro blastogenic reactivity to mitogens and antigens. Cutaneous anergy to a variety of common skin test antigens was noted. These observations may reflect an inherited abnormality in immune function, or the depressed immune function may result from the viral infection of EV.

Entities:  

Mesh:

Year:  1977        PMID: 848981

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  10 in total

Review 1.  Immunopathology of papillomavirus-induced tumors in different tissues.

Authors:  S Jablonska; G Orth; M A Lutzner
Journal:  Springer Semin Immunopathol       Date:  1982

2.  Papillomavirus DNA in warts of immunosuppressed renal allograft recipients.

Authors:  A Gassenmaier; P Fuchs; H Schell; H Pfister
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

Review 3.  Warts and all: human papillomavirus in primary immunodeficiencies.

Authors:  Jennifer W Leiding; Steven M Holland
Journal:  J Allergy Clin Immunol       Date:  2012-10-01       Impact factor: 10.793

4.  Combined immunodeficiency associated with DOCK8 mutations.

Authors:  Qian Zhang; Jeremiah C Davis; Ian T Lamborn; Alexandra F Freeman; Huie Jing; Amanda J Favreau; Helen F Matthews; Joie Davis; Maria L Turner; Gulbu Uzel; Steven M Holland; Helen C Su
Journal:  N Engl J Med       Date:  2009-09-23       Impact factor: 91.245

5.  EVER2 deficiency is associated with mild T-cell abnormalities.

Authors:  Amandine Crequer; Capucine Picard; Vincent Pedergnana; Annick Lim; Shen-Ying Zhang; Laurent Abel; Slawomir Majewski; Jean-Laurent Casanova; Stefania Jablonska; Gerard Orth; Emmanuelle Jouanguy
Journal:  J Clin Immunol       Date:  2012-08-19       Impact factor: 8.317

6.  Epidermodysplasia verruciformis induced by a new human papillomavirus (HPV-8). Report of a case without immune dysfunction. Effect of treatment with an aromatic retinoid.

Authors:  A L Claudy; J L Touraine; D Mitanne
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

Review 7.  The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections.

Authors:  Maciej Lazarczyk; Patricia Cassonnet; Christian Pons; Yves Jacob; Michel Favre
Journal:  Microbiol Mol Biol Rev       Date:  2009-06       Impact factor: 11.056

8.  EVER proteins, key elements of the natural anti-human papillomavirus barrier, are regulated upon T-cell activation.

Authors:  Maciej Lazarczyk; Cécile Dalard; Myriam Hayder; Loïc Dupre; Béatrice Pignolet; Slawomir Majewski; Francoise Vuillier; Michel Favre; Roland S Liblau
Journal:  PLoS One       Date:  2012-06-28       Impact factor: 3.240

9.  Epidermodysplasia Verruciformis: Inborn Errors of Immunity to Human Beta-Papillomaviruses.

Authors:  Sarah J de Jong; Elias Imahorn; Peter Itin; Jouni Uitto; Gérard Orth; Emmanuelle Jouanguy; Jean-Laurent Casanova; Bettina Burger
Journal:  Front Microbiol       Date:  2018-06-12       Impact factor: 5.640

10.  The transmembrane channel-like protein family and human papillomaviruses: Insights into epidermodysplasia verruciformis and progression to squamous cell carcinoma.

Authors:  Jaime S Horton; Alexander J Stokes
Journal:  Oncoimmunology       Date:  2014-04-15       Impact factor: 8.110

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.